Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/15/2025

Ovarian Stimulation for IUI Cycles

Primary Recommendation for Ovarian Stimulation

  • The American Society for Reproductive Medicine recommends that IUI should be combined with ovarian stimulation to improve live birth rates in couples with unexplained infertility and men with a total motile sperm count (TMSC) above 10 million, representing moderate-strength evidence from comprehensive international guidelines 1, 2

FSH vs. Clomiphene Citrate: The Evidence

  • Gonadotropins (FSH) yield significantly higher pregnancy rates than clomiphene citrate (OR = 1.8, 95% CI 1.2–2.7), though clomiphene remains an acceptable alternative when cost is a primary concern 3
  • Clomiphene citrate or tamoxifen are acceptable alternatives to low-dose gonadotropins for lower multiple pregnancy rates and reduced costs, although at a lower live birth rate than with gonadotropins 2, 3

Optimal FSH Dosing Protocol

  • When gonadotropins are used in IUI, regimens with 75 IU or lower should be used because higher doses have similar pregnancy rates but increase multiple pregnancy rates 2, 3, 4

Critical Safety Parameters

  • To prevent high rates of multiple gestation pregnancies in IUI with ovarian stimulation, IUI should be withheld when more than two dominant follicles >15 mm or more than five follicles >10 mm at the time of hCG injection or LH surge are present 2, 3, 4, 5
  • Multiple pregnancy risk is 10-20% with gonadotropin stimulation without proper cycle management 5
  • The goal is to achieve exactly 2 mature follicles (>15mm) to balance success against multiple pregnancy risk 4
  • Compared to one dominant follicle, pregnancy rates increase by 5%, 8%, and 8% with two, three, or four dominant follicles, respectively, but multiple pregnancy risk increases to 6%, 14%, and 10% respectively 3

Cost-Effectiveness Considerations

  • In couples with unexplained infertility and men with a TMSC of >10 million and a prognosis of pregnancy without assistance <30% within a year, at least three cycles of IUI with ovarian stimulation is the most cost-effective option 1, 2, 6
  • IUI with ovarian stimulation is more cost-effective than proceeding directly to IVF, particularly when strict cancellation criteria minimize multiple pregnancies 6
  • At least 3 consecutive IUI cycles should be performed before transitioning to IVF/ICSI, as cycle fecundity remains acceptable through cycle 3 4, 5
  • When IVF with elective single embryo transfer achieves ongoing pregnancy rates exceeding 38%, it becomes preferable to IUI with ovarian stimulation 6

Common Pitfalls to Avoid

  • Do not add GnRH agonists to gonadotropins as they increase multiple pregnancy rates and costs without improving pregnancy rates 3, 5
  • Do not use FSH doses higher than 75 IU/day as a starting dose, as higher doses yield similar pregnancy rates but significantly increase multiple pregnancy risk 2, 3
  • Do not proceed with insemination when >2 follicles >15mm develop, as this dramatically increases high-order multiple pregnancy risk without proportional benefit 4, 5